The Leadership Team at Equillium is responsible for setting the strategic vision and direction of the company, overseeing operations, and ensuring the successful development and commercialization of innovative therapies for severe autoimmune and inflammatory diseases. Comprising experienced executives in finance, operations, and scientific development, this team collaboratively drives decision-making, fosters a culture of innovation, and ensures alignment with the company's mission to meet critical patient needs.